✦ LIBER ✦

A randomized, double-blind trial of lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease

✍ Scribed by Athos Bousvaros; Stefano Guandalini; Robert N Baldassano; Christine Botelho; Jonathan Evans; George D Ferry; Barry Goldin; Lori Hartigan; Subra Kugathasan; Joseph Levy; Karen F Murray; Maria Oliva-Hemker; Joel R Rosh; Vasundhara Tolia; Anna Zholudev; Jon A Vanderhoof; Patricia L Hibberd

Book ID: 110087269
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 101 KB
Volume: 11
Category: Article
ISSN: 1078-0998
DOI: 10.1097/01.mib.0000175905.00212.2c

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized double-blind placebo-contro

A randomized double-blind placebo-controlled trial of Lactobacillus GG for abdominal pain disorders in children

✍ A. GAWROŃSKA; P. DZIECHCIARZ; A. HORVATH; H. SZAJEWSKA 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 488 KB

Ineffectiveness of Lactobacillus GG as a

Ineffectiveness of Lactobacillus GG as an adjunct to lactulose for the treatment of constipation in children: A double-blind, placebo-controlled randomized trial

✍ Aleksandra Banaszkiewicz; Hania Szajewska 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 181 KB

A randomized, placebo-controlled, double

A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group

✍ LR Sutherland; F Martin; RJ Bailey; RN Fedorak; M Poleski; C Dallaire; R Rossman 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 345 KB

Pardoprunox as adjunct therapy to levodo

Pardoprunox as adjunct therapy to levodopa in patients with Parkinson’s disease experiencing motor fluctuations: Results of a double-blind, randomized, placebo-controlled, trial

✍ O. Rascol; J. Bronzova; R.A. Hauser; A.E. Lang; C. Sampaio; A. Theeuwes; S.V. va 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 436 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-α, in patients with corticosteroid-dependent Crohn's disease

✍ B. G. Feagan; W. J. Sandborn; J. P. Baker; F. Cominelli; L. R. Sutherland; C. O 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 331 KB

Addition of the neurokinin 1 receptor an

Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting : Results from a randomized, double-blind, placebo-controlled trial in Latin America

✍ Sergio Poli-Bigelli; Jose Rodrigues-Pereira; Alexandra D. Carides; Guoguang Juli 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 1 views